EGFR Gene Amplification
3 clinical trials · Condition
◉ Watch EGFR Gene Amplification
| Record | Firm | Date |
|---|---|---|
| 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma (NCT03732352) | Jonsson Comprehensive Cancer Center | 2018-11-28 |
| Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation (NCT03065387) | M.D. Anderson Cancer Center | 2017-10-31 |
| Combination of Metformin With Gefitinib to Treat NSCLC (NCT01864681) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2013-05-01 |
Track EGFR Gene Amplification automatically
Every clearance here is in the API, with alerts when new ones post.